Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Rx-3117
2. Tv-1360
1. Rx-3117
2. 865838-26-2
3. Roducitabine
4. Rx3117
5. Tv-1360
6. Roducitabine [usan]
7. Rx 3117
8. 0z4a82i0jo
9. 4-amino-1-[(1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]pyrimidin-2-one
10. 1-[(1s,4r,5s)-2-fluoro-3-(hydroxymethyl)-4,5-dihydroxy-2-cyclopentenyl]cytosine
11. 4-amino-1-((1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)-2-cyclopenten-1-yl)-2(1h)-pyrimidinone
12. 4-amino-1-((1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl)pyrimidin-2(1h)-one
13. 4-amino-1-[(1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)-2-cyclopenten-1-yl]-2(1h)-pyrimidinone
14. 4-amino-1-[(1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]-1,2-dihydropyrimidin-2-one
15. 4-amino-1-((1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl)pyrimidin-2-one
16. 4-amino-1-[(1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopent-2-en-1-yl]pyrimidin-2(1h)-one
17. Fluorocyclopentenyl Cytosine
18. Fluorocyclopentenyl-cytosine
19. Roducitabine [inn]
20. Unii-0z4a82i0jo
21. Schembl4409591
22. Chembl2064455
23. Chebi:147412
24. Dtxsid101113297
25. Ex-a4776
26. Nsc785657
27. Who 11374
28. Zinc84651969
29. Cs-3947
30. Nsc-785657
31. Ncgc00485875-01
32. Ncgc00485875-02
33. Ac-35336
34. Hy-15228
35. A900305
36. S900007480
37. 2(1h)-pyrimidinone, 4-amino-1-((1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)-2-cyclopenten-1-yl)-
38. 4-amino-1-((1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl) Cyclopent-2-en-1-yl) Pyrimidin-2-one
39. 4-amino-1-((1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)-cyclopent-2-en-1-yl)-pyrimidin-2(1h)-one
| Molecular Weight | 257.22 g/mol |
|---|---|
| Molecular Formula | C10H12FN3O4 |
| XLogP3 | -2.6 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 257.08118403 g/mol |
| Monoisotopic Mass | 257.08118403 g/mol |
| Topological Polar Surface Area | 119 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 474 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
43
PharmaCompass offers a list of RX-3117 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right RX-3117 manufacturer or RX-3117 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred RX-3117 manufacturer or RX-3117 supplier.
PharmaCompass also assists you with knowing the RX-3117 API Price utilized in the formulation of products. RX-3117 API Price is not always fixed or binding as the RX-3117 Price is obtained through a variety of data sources. The RX-3117 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A RX 3117 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of RX 3117, including repackagers and relabelers. The FDA regulates RX 3117 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. RX 3117 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A RX 3117 supplier is an individual or a company that provides RX 3117 active pharmaceutical ingredient (API) or RX 3117 finished formulations upon request. The RX 3117 suppliers may include RX 3117 API manufacturers, exporters, distributors and traders.
RX 3117 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of RX 3117 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right RX 3117 GMP manufacturer or RX 3117 GMP API supplier for your needs.
A RX 3117 CoA (Certificate of Analysis) is a formal document that attests to RX 3117's compliance with RX 3117 specifications and serves as a tool for batch-level quality control.
RX 3117 CoA mostly includes findings from lab analyses of a specific batch. For each RX 3117 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
RX 3117 may be tested according to a variety of international standards, such as European Pharmacopoeia (RX 3117 EP), RX 3117 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (RX 3117 USP).
